nodes	percent_of_prediction	percent_of_DWPC	metapath
Morphine—UGT2B7—Epirubicin—thyroid cancer	0.248	0.365	CbGbCtD
Morphine—UGT1A1—Sorafenib—thyroid cancer	0.188	0.276	CbGbCtD
Morphine—CYP2C8—Sorafenib—thyroid cancer	0.0551	0.0809	CbGbCtD
Morphine—ABCB1—Sorafenib—thyroid cancer	0.0373	0.0548	CbGbCtD
Morphine—CYP3A4—Vandetanib—thyroid cancer	0.0371	0.0544	CbGbCtD
Morphine—CYP2D6—Sorafenib—thyroid cancer	0.0352	0.0516	CbGbCtD
Morphine—ABCB1—Doxorubicin—thyroid cancer	0.0226	0.0332	CbGbCtD
Morphine—CYP3A4—Sorafenib—thyroid cancer	0.0224	0.0328	CbGbCtD
Morphine—CYP2D6—Doxorubicin—thyroid cancer	0.0213	0.0313	CbGbCtD
Morphine—CYP3A4—Doxorubicin—thyroid cancer	0.0136	0.0199	CbGbCtD
Morphine—Fatigue—Sorafenib—thyroid cancer	0.000463	0.00177	CcSEcCtD
Morphine—Pain—Sorafenib—thyroid cancer	0.000459	0.00176	CcSEcCtD
Morphine—Constipation—Sorafenib—thyroid cancer	0.000459	0.00176	CcSEcCtD
Morphine—Pulmonary oedema—Doxorubicin—thyroid cancer	0.000458	0.00175	CcSEcCtD
Morphine—Hypertonia—Doxorubicin—thyroid cancer	0.000451	0.00173	CcSEcCtD
Morphine—Eye pain—Epirubicin—thyroid cancer	0.000447	0.00171	CcSEcCtD
Morphine—Mental disability—Doxorubicin—thyroid cancer	0.000447	0.00171	CcSEcCtD
Morphine—Sepsis—Doxorubicin—thyroid cancer	0.000447	0.00171	CcSEcCtD
Morphine—Gastrointestinal pain—Sorafenib—thyroid cancer	0.000439	0.00168	CcSEcCtD
Morphine—Phlebitis—Doxorubicin—thyroid cancer	0.000434	0.00166	CcSEcCtD
Morphine—Urticaria—Sorafenib—thyroid cancer	0.000427	0.00163	CcSEcCtD
Morphine—Abdominal pain—Sorafenib—thyroid cancer	0.000425	0.00162	CcSEcCtD
Morphine—Body temperature increased—Sorafenib—thyroid cancer	0.000425	0.00162	CcSEcCtD
Morphine—Renal impairment—Epirubicin—thyroid cancer	0.000424	0.00162	CcSEcCtD
Morphine—Dermatitis bullous—Epirubicin—thyroid cancer	0.000423	0.00162	CcSEcCtD
Morphine—Anaphylactoid reaction—Epirubicin—thyroid cancer	0.000417	0.0016	CcSEcCtD
Morphine—Eye pain—Doxorubicin—thyroid cancer	0.000414	0.00158	CcSEcCtD
Morphine—Lethargy—Epirubicin—thyroid cancer	0.000412	0.00158	CcSEcCtD
Morphine—Hyponatraemia—Epirubicin—thyroid cancer	0.000406	0.00155	CcSEcCtD
Morphine—Diplopia—Epirubicin—thyroid cancer	0.000404	0.00154	CcSEcCtD
Morphine—Osteoarthritis—Epirubicin—thyroid cancer	0.000404	0.00154	CcSEcCtD
Morphine—Affect lability—Epirubicin—thyroid cancer	0.000398	0.00152	CcSEcCtD
Morphine—Hypersensitivity—Sorafenib—thyroid cancer	0.000396	0.00151	CcSEcCtD
Morphine—Renal impairment—Doxorubicin—thyroid cancer	0.000393	0.0015	CcSEcCtD
Morphine—Dermatitis bullous—Doxorubicin—thyroid cancer	0.000391	0.0015	CcSEcCtD
Morphine—Anaphylactoid reaction—Doxorubicin—thyroid cancer	0.000386	0.00148	CcSEcCtD
Morphine—Asthenia—Sorafenib—thyroid cancer	0.000385	0.00147	CcSEcCtD
Morphine—Cardiac arrest—Epirubicin—thyroid cancer	0.000384	0.00147	CcSEcCtD
Morphine—Mood swings—Epirubicin—thyroid cancer	0.000383	0.00146	CcSEcCtD
Morphine—Lethargy—Doxorubicin—thyroid cancer	0.000381	0.00146	CcSEcCtD
Morphine—Pruritus—Sorafenib—thyroid cancer	0.00038	0.00145	CcSEcCtD
Morphine—Ataxia—Epirubicin—thyroid cancer	0.00038	0.00145	CcSEcCtD
Morphine—Dehydration—Epirubicin—thyroid cancer	0.000376	0.00144	CcSEcCtD
Morphine—Hyponatraemia—Doxorubicin—thyroid cancer	0.000375	0.00143	CcSEcCtD
Morphine—Osteoarthritis—Doxorubicin—thyroid cancer	0.000374	0.00143	CcSEcCtD
Morphine—Diplopia—Doxorubicin—thyroid cancer	0.000374	0.00143	CcSEcCtD
Morphine—Liver function test abnormal—Epirubicin—thyroid cancer	0.000373	0.00143	CcSEcCtD
Morphine—Dry skin—Epirubicin—thyroid cancer	0.00037	0.00142	CcSEcCtD
Morphine—Orthostatic hypotension—Epirubicin—thyroid cancer	0.000369	0.00141	CcSEcCtD
Morphine—Abdominal pain upper—Epirubicin—thyroid cancer	0.000369	0.00141	CcSEcCtD
Morphine—Affect lability—Doxorubicin—thyroid cancer	0.000368	0.00141	CcSEcCtD
Morphine—Hypokalaemia—Epirubicin—thyroid cancer	0.000368	0.00141	CcSEcCtD
Morphine—Diarrhoea—Sorafenib—thyroid cancer	0.000368	0.00141	CcSEcCtD
Morphine—Breast disorder—Epirubicin—thyroid cancer	0.000365	0.0014	CcSEcCtD
Morphine—Nasopharyngitis—Epirubicin—thyroid cancer	0.000361	0.00138	CcSEcCtD
Morphine—Cardiac arrest—Doxorubicin—thyroid cancer	0.000355	0.00136	CcSEcCtD
Morphine—Dizziness—Sorafenib—thyroid cancer	0.000355	0.00136	CcSEcCtD
Morphine—Mood swings—Doxorubicin—thyroid cancer	0.000354	0.00135	CcSEcCtD
Morphine—Abdominal distension—Epirubicin—thyroid cancer	0.000351	0.00134	CcSEcCtD
Morphine—Ataxia—Doxorubicin—thyroid cancer	0.000351	0.00134	CcSEcCtD
Morphine—Dysphagia—Epirubicin—thyroid cancer	0.000349	0.00133	CcSEcCtD
Morphine—Influenza—Epirubicin—thyroid cancer	0.000349	0.00133	CcSEcCtD
Morphine—Dehydration—Doxorubicin—thyroid cancer	0.000348	0.00133	CcSEcCtD
Morphine—Eosinophilia—Epirubicin—thyroid cancer	0.000346	0.00132	CcSEcCtD
Morphine—Liver function test abnormal—Doxorubicin—thyroid cancer	0.000345	0.00132	CcSEcCtD
Morphine—Dry skin—Doxorubicin—thyroid cancer	0.000343	0.00131	CcSEcCtD
Morphine—Vomiting—Sorafenib—thyroid cancer	0.000342	0.00131	CcSEcCtD
Morphine—Orthostatic hypotension—Doxorubicin—thyroid cancer	0.000341	0.00131	CcSEcCtD
Morphine—Abdominal pain upper—Doxorubicin—thyroid cancer	0.000341	0.00131	CcSEcCtD
Morphine—Hypokalaemia—Doxorubicin—thyroid cancer	0.00034	0.0013	CcSEcCtD
Morphine—Rash—Sorafenib—thyroid cancer	0.000339	0.0013	CcSEcCtD
Morphine—Dermatitis—Sorafenib—thyroid cancer	0.000338	0.00129	CcSEcCtD
Morphine—Breast disorder—Doxorubicin—thyroid cancer	0.000338	0.00129	CcSEcCtD
Morphine—Headache—Sorafenib—thyroid cancer	0.000337	0.00129	CcSEcCtD
Morphine—Nasopharyngitis—Doxorubicin—thyroid cancer	0.000334	0.00128	CcSEcCtD
Morphine—Dysuria—Epirubicin—thyroid cancer	0.000326	0.00125	CcSEcCtD
Morphine—Abdominal distension—Doxorubicin—thyroid cancer	0.000325	0.00124	CcSEcCtD
Morphine—Influenza—Doxorubicin—thyroid cancer	0.000323	0.00124	CcSEcCtD
Morphine—Dysphagia—Doxorubicin—thyroid cancer	0.000323	0.00124	CcSEcCtD
Morphine—Eosinophilia—Doxorubicin—thyroid cancer	0.00032	0.00122	CcSEcCtD
Morphine—Nausea—Sorafenib—thyroid cancer	0.000319	0.00122	CcSEcCtD
Morphine—Weight decreased—Epirubicin—thyroid cancer	0.000316	0.00121	CcSEcCtD
Morphine—Hyperglycaemia—Epirubicin—thyroid cancer	0.000315	0.0012	CcSEcCtD
Morphine—Drowsiness—Epirubicin—thyroid cancer	0.000311	0.00119	CcSEcCtD
Morphine—Renal failure—Epirubicin—thyroid cancer	0.000306	0.00117	CcSEcCtD
Morphine—Stomatitis—Epirubicin—thyroid cancer	0.000303	0.00116	CcSEcCtD
Morphine—Conjunctivitis—Epirubicin—thyroid cancer	0.000303	0.00116	CcSEcCtD
Morphine—Urinary tract infection—Epirubicin—thyroid cancer	0.000303	0.00116	CcSEcCtD
Morphine—Dysuria—Doxorubicin—thyroid cancer	0.000302	0.00116	CcSEcCtD
Morphine—Sweating—Epirubicin—thyroid cancer	0.000298	0.00114	CcSEcCtD
Morphine—Hepatobiliary disease—Epirubicin—thyroid cancer	0.000294	0.00113	CcSEcCtD
Morphine—Weight decreased—Doxorubicin—thyroid cancer	0.000292	0.00112	CcSEcCtD
Morphine—Hyperglycaemia—Doxorubicin—thyroid cancer	0.000291	0.00111	CcSEcCtD
Morphine—Drowsiness—Doxorubicin—thyroid cancer	0.000288	0.0011	CcSEcCtD
Morphine—Bradycardia—Epirubicin—thyroid cancer	0.000284	0.00109	CcSEcCtD
Morphine—Renal failure—Doxorubicin—thyroid cancer	0.000283	0.00108	CcSEcCtD
Morphine—Stomatitis—Doxorubicin—thyroid cancer	0.000281	0.00107	CcSEcCtD
Morphine—Rhinitis—Epirubicin—thyroid cancer	0.00028	0.00107	CcSEcCtD
Morphine—Conjunctivitis—Doxorubicin—thyroid cancer	0.00028	0.00107	CcSEcCtD
Morphine—Urinary tract infection—Doxorubicin—thyroid cancer	0.00028	0.00107	CcSEcCtD
Morphine—Hepatitis—Epirubicin—thyroid cancer	0.000279	0.00107	CcSEcCtD
Morphine—Hypoaesthesia—Epirubicin—thyroid cancer	0.000278	0.00106	CcSEcCtD
Morphine—Sweating—Doxorubicin—thyroid cancer	0.000276	0.00106	CcSEcCtD
Morphine—Urinary tract disorder—Epirubicin—thyroid cancer	0.000276	0.00106	CcSEcCtD
Morphine—Oedema peripheral—Epirubicin—thyroid cancer	0.000275	0.00105	CcSEcCtD
Morphine—Connective tissue disorder—Epirubicin—thyroid cancer	0.000275	0.00105	CcSEcCtD
Morphine—Urethral disorder—Epirubicin—thyroid cancer	0.000274	0.00105	CcSEcCtD
Morphine—Hepatobiliary disease—Doxorubicin—thyroid cancer	0.000272	0.00104	CcSEcCtD
Morphine—Visual impairment—Epirubicin—thyroid cancer	0.000269	0.00103	CcSEcCtD
Morphine—Bradycardia—Doxorubicin—thyroid cancer	0.000263	0.00101	CcSEcCtD
Morphine—Eye disorder—Epirubicin—thyroid cancer	0.000261	0.000999	CcSEcCtD
Morphine—Flushing—Epirubicin—thyroid cancer	0.000259	0.000992	CcSEcCtD
Morphine—Rhinitis—Doxorubicin—thyroid cancer	0.000259	0.000991	CcSEcCtD
Morphine—Hepatitis—Doxorubicin—thyroid cancer	0.000259	0.000989	CcSEcCtD
Morphine—Hypoaesthesia—Doxorubicin—thyroid cancer	0.000257	0.000984	CcSEcCtD
Morphine—Urinary tract disorder—Doxorubicin—thyroid cancer	0.000255	0.000976	CcSEcCtD
Morphine—Oedema peripheral—Doxorubicin—thyroid cancer	0.000255	0.000974	CcSEcCtD
Morphine—Connective tissue disorder—Doxorubicin—thyroid cancer	0.000254	0.000972	CcSEcCtD
Morphine—Angiopathy—Epirubicin—thyroid cancer	0.000254	0.000969	CcSEcCtD
Morphine—Urethral disorder—Doxorubicin—thyroid cancer	0.000253	0.000969	CcSEcCtD
Morphine—Mediastinal disorder—Epirubicin—thyroid cancer	0.000252	0.000963	CcSEcCtD
Morphine—Chills—Epirubicin—thyroid cancer	0.000251	0.000959	CcSEcCtD
Morphine—Visual impairment—Doxorubicin—thyroid cancer	0.000249	0.000953	CcSEcCtD
Morphine—Mental disorder—Epirubicin—thyroid cancer	0.000245	0.000936	CcSEcCtD
Morphine—Erythema—Epirubicin—thyroid cancer	0.000243	0.00093	CcSEcCtD
Morphine—Malnutrition—Epirubicin—thyroid cancer	0.000243	0.00093	CcSEcCtD
Morphine—Eye disorder—Doxorubicin—thyroid cancer	0.000242	0.000924	CcSEcCtD
Morphine—Flushing—Doxorubicin—thyroid cancer	0.00024	0.000918	CcSEcCtD
Morphine—Flatulence—Epirubicin—thyroid cancer	0.00024	0.000917	CcSEcCtD
Morphine—Tension—Epirubicin—thyroid cancer	0.000239	0.000913	CcSEcCtD
Morphine—Dysgeusia—Epirubicin—thyroid cancer	0.000238	0.000911	CcSEcCtD
Morphine—Nervousness—Epirubicin—thyroid cancer	0.000236	0.000903	CcSEcCtD
Morphine—Back pain—Epirubicin—thyroid cancer	0.000235	0.0009	CcSEcCtD
Morphine—Angiopathy—Doxorubicin—thyroid cancer	0.000235	0.000897	CcSEcCtD
Morphine—Muscle spasms—Epirubicin—thyroid cancer	0.000234	0.000894	CcSEcCtD
Morphine—Mediastinal disorder—Doxorubicin—thyroid cancer	0.000233	0.000891	CcSEcCtD
Morphine—Chills—Doxorubicin—thyroid cancer	0.000232	0.000887	CcSEcCtD
Morphine—Vision blurred—Epirubicin—thyroid cancer	0.000229	0.000877	CcSEcCtD
Morphine—Mental disorder—Doxorubicin—thyroid cancer	0.000227	0.000866	CcSEcCtD
Morphine—Ill-defined disorder—Epirubicin—thyroid cancer	0.000226	0.000863	CcSEcCtD
Morphine—Erythema—Doxorubicin—thyroid cancer	0.000225	0.000861	CcSEcCtD
Morphine—Malnutrition—Doxorubicin—thyroid cancer	0.000225	0.000861	CcSEcCtD
Morphine—Anaemia—Epirubicin—thyroid cancer	0.000225	0.00086	CcSEcCtD
Morphine—Agitation—Epirubicin—thyroid cancer	0.000224	0.000855	CcSEcCtD
Morphine—Flatulence—Doxorubicin—thyroid cancer	0.000222	0.000848	CcSEcCtD
Morphine—Tension—Doxorubicin—thyroid cancer	0.000221	0.000845	CcSEcCtD
Morphine—Dysgeusia—Doxorubicin—thyroid cancer	0.00022	0.000843	CcSEcCtD
Morphine—Malaise—Epirubicin—thyroid cancer	0.000219	0.000839	CcSEcCtD
Morphine—Nervousness—Doxorubicin—thyroid cancer	0.000219	0.000836	CcSEcCtD
Morphine—Vertigo—Epirubicin—thyroid cancer	0.000219	0.000836	CcSEcCtD
Morphine—Syncope—Epirubicin—thyroid cancer	0.000218	0.000834	CcSEcCtD
Morphine—Leukopenia—Epirubicin—thyroid cancer	0.000218	0.000833	CcSEcCtD
Morphine—Back pain—Doxorubicin—thyroid cancer	0.000218	0.000833	CcSEcCtD
Morphine—Muscle spasms—Doxorubicin—thyroid cancer	0.000216	0.000827	CcSEcCtD
Morphine—Palpitations—Epirubicin—thyroid cancer	0.000215	0.000822	CcSEcCtD
Morphine—Loss of consciousness—Epirubicin—thyroid cancer	0.000214	0.000818	CcSEcCtD
Morphine—Cough—Epirubicin—thyroid cancer	0.000212	0.000812	CcSEcCtD
Morphine—Vision blurred—Doxorubicin—thyroid cancer	0.000212	0.000811	CcSEcCtD
Morphine—Convulsion—Epirubicin—thyroid cancer	0.000211	0.000806	CcSEcCtD
Morphine—Hypertension—Epirubicin—thyroid cancer	0.00021	0.000803	CcSEcCtD
Morphine—Ill-defined disorder—Doxorubicin—thyroid cancer	0.000209	0.000799	CcSEcCtD
Morphine—Anaemia—Doxorubicin—thyroid cancer	0.000208	0.000796	CcSEcCtD
Morphine—Chest pain—Epirubicin—thyroid cancer	0.000207	0.000792	CcSEcCtD
Morphine—Arthralgia—Epirubicin—thyroid cancer	0.000207	0.000792	CcSEcCtD
Morphine—Agitation—Doxorubicin—thyroid cancer	0.000207	0.000791	CcSEcCtD
Morphine—Anxiety—Epirubicin—thyroid cancer	0.000206	0.000789	CcSEcCtD
Morphine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—thyroid cancer	0.000206	0.000786	CcSEcCtD
Morphine—Discomfort—Epirubicin—thyroid cancer	0.000205	0.000782	CcSEcCtD
Morphine—Malaise—Doxorubicin—thyroid cancer	0.000203	0.000776	CcSEcCtD
Morphine—Dry mouth—Epirubicin—thyroid cancer	0.000203	0.000775	CcSEcCtD
Morphine—Vertigo—Doxorubicin—thyroid cancer	0.000202	0.000773	CcSEcCtD
Morphine—Syncope—Doxorubicin—thyroid cancer	0.000202	0.000772	CcSEcCtD
Morphine—Leukopenia—Doxorubicin—thyroid cancer	0.000201	0.00077	CcSEcCtD
Morphine—Confusional state—Epirubicin—thyroid cancer	0.0002	0.000765	CcSEcCtD
Morphine—Palpitations—Doxorubicin—thyroid cancer	0.000199	0.000761	CcSEcCtD
Morphine—Anaphylactic shock—Epirubicin—thyroid cancer	0.000199	0.000759	CcSEcCtD
Morphine—Oedema—Epirubicin—thyroid cancer	0.000199	0.000759	CcSEcCtD
Morphine—Loss of consciousness—Doxorubicin—thyroid cancer	0.000198	0.000756	CcSEcCtD
Morphine—Infection—Epirubicin—thyroid cancer	0.000197	0.000754	CcSEcCtD
Morphine—Cough—Doxorubicin—thyroid cancer	0.000196	0.000751	CcSEcCtD
Morphine—Shock—Epirubicin—thyroid cancer	0.000195	0.000747	CcSEcCtD
Morphine—Convulsion—Doxorubicin—thyroid cancer	0.000195	0.000746	CcSEcCtD
Morphine—Nervous system disorder—Epirubicin—thyroid cancer	0.000195	0.000745	CcSEcCtD
Morphine—Thrombocytopenia—Epirubicin—thyroid cancer	0.000194	0.000743	CcSEcCtD
Morphine—Hypertension—Doxorubicin—thyroid cancer	0.000194	0.000743	CcSEcCtD
Morphine—Tachycardia—Epirubicin—thyroid cancer	0.000194	0.000741	CcSEcCtD
Morphine—Skin disorder—Epirubicin—thyroid cancer	0.000193	0.000737	CcSEcCtD
Morphine—Hyperhidrosis—Epirubicin—thyroid cancer	0.000192	0.000734	CcSEcCtD
Morphine—Chest pain—Doxorubicin—thyroid cancer	0.000192	0.000733	CcSEcCtD
Morphine—Arthralgia—Doxorubicin—thyroid cancer	0.000192	0.000733	CcSEcCtD
Morphine—Anxiety—Doxorubicin—thyroid cancer	0.000191	0.00073	CcSEcCtD
Morphine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—thyroid cancer	0.00019	0.000728	CcSEcCtD
Morphine—Discomfort—Doxorubicin—thyroid cancer	0.000189	0.000724	CcSEcCtD
Morphine—Anorexia—Epirubicin—thyroid cancer	0.000189	0.000724	CcSEcCtD
Morphine—Dry mouth—Doxorubicin—thyroid cancer	0.000187	0.000717	CcSEcCtD
Morphine—Hypotension—Epirubicin—thyroid cancer	0.000186	0.000709	CcSEcCtD
Morphine—Confusional state—Doxorubicin—thyroid cancer	0.000185	0.000708	CcSEcCtD
Morphine—Oedema—Doxorubicin—thyroid cancer	0.000184	0.000702	CcSEcCtD
Morphine—Anaphylactic shock—Doxorubicin—thyroid cancer	0.000184	0.000702	CcSEcCtD
Morphine—Infection—Doxorubicin—thyroid cancer	0.000182	0.000698	CcSEcCtD
Morphine—Musculoskeletal discomfort—Epirubicin—thyroid cancer	0.000181	0.000692	CcSEcCtD
Morphine—Shock—Doxorubicin—thyroid cancer	0.000181	0.000691	CcSEcCtD
Morphine—Nervous system disorder—Doxorubicin—thyroid cancer	0.00018	0.000689	CcSEcCtD
Morphine—Thrombocytopenia—Doxorubicin—thyroid cancer	0.00018	0.000688	CcSEcCtD
Morphine—Insomnia—Epirubicin—thyroid cancer	0.00018	0.000687	CcSEcCtD
Morphine—Tachycardia—Doxorubicin—thyroid cancer	0.000179	0.000686	CcSEcCtD
Morphine—Skin disorder—Doxorubicin—thyroid cancer	0.000178	0.000682	CcSEcCtD
Morphine—Paraesthesia—Epirubicin—thyroid cancer	0.000178	0.000682	CcSEcCtD
Morphine—Hyperhidrosis—Doxorubicin—thyroid cancer	0.000178	0.000679	CcSEcCtD
Morphine—Dyspnoea—Epirubicin—thyroid cancer	0.000177	0.000677	CcSEcCtD
Morphine—Somnolence—Epirubicin—thyroid cancer	0.000176	0.000675	CcSEcCtD
Morphine—Anorexia—Doxorubicin—thyroid cancer	0.000175	0.00067	CcSEcCtD
Morphine—Dyspepsia—Epirubicin—thyroid cancer	0.000175	0.000668	CcSEcCtD
Morphine—Decreased appetite—Epirubicin—thyroid cancer	0.000173	0.00066	CcSEcCtD
Morphine—Hypotension—Doxorubicin—thyroid cancer	0.000172	0.000656	CcSEcCtD
Morphine—Gastrointestinal disorder—Epirubicin—thyroid cancer	0.000171	0.000655	CcSEcCtD
Morphine—Fatigue—Epirubicin—thyroid cancer	0.000171	0.000655	CcSEcCtD
Morphine—Pain—Epirubicin—thyroid cancer	0.00017	0.000649	CcSEcCtD
Morphine—Constipation—Epirubicin—thyroid cancer	0.00017	0.000649	CcSEcCtD
Morphine—Musculoskeletal discomfort—Doxorubicin—thyroid cancer	0.000167	0.00064	CcSEcCtD
Morphine—Insomnia—Doxorubicin—thyroid cancer	0.000166	0.000635	CcSEcCtD
Morphine—Paraesthesia—Doxorubicin—thyroid cancer	0.000165	0.000631	CcSEcCtD
Morphine—Dyspnoea—Doxorubicin—thyroid cancer	0.000164	0.000626	CcSEcCtD
Morphine—Feeling abnormal—Epirubicin—thyroid cancer	0.000164	0.000626	CcSEcCtD
Morphine—Somnolence—Doxorubicin—thyroid cancer	0.000163	0.000624	CcSEcCtD
Morphine—Gastrointestinal pain—Epirubicin—thyroid cancer	0.000162	0.000621	CcSEcCtD
Morphine—Dyspepsia—Doxorubicin—thyroid cancer	0.000162	0.000618	CcSEcCtD
Morphine—Decreased appetite—Doxorubicin—thyroid cancer	0.00016	0.000611	CcSEcCtD
Morphine—Gastrointestinal disorder—Doxorubicin—thyroid cancer	0.000159	0.000606	CcSEcCtD
Morphine—Fatigue—Doxorubicin—thyroid cancer	0.000158	0.000606	CcSEcCtD
Morphine—Urticaria—Epirubicin—thyroid cancer	0.000158	0.000603	CcSEcCtD
Morphine—Pain—Doxorubicin—thyroid cancer	0.000157	0.000601	CcSEcCtD
Morphine—Constipation—Doxorubicin—thyroid cancer	0.000157	0.000601	CcSEcCtD
Morphine—Abdominal pain—Epirubicin—thyroid cancer	0.000157	0.0006	CcSEcCtD
Morphine—Body temperature increased—Epirubicin—thyroid cancer	0.000157	0.0006	CcSEcCtD
Morphine—Feeling abnormal—Doxorubicin—thyroid cancer	0.000151	0.000579	CcSEcCtD
Morphine—Gastrointestinal pain—Doxorubicin—thyroid cancer	0.00015	0.000574	CcSEcCtD
Morphine—Hypersensitivity—Epirubicin—thyroid cancer	0.000146	0.000559	CcSEcCtD
Morphine—Urticaria—Doxorubicin—thyroid cancer	0.000146	0.000558	CcSEcCtD
Morphine—Body temperature increased—Doxorubicin—thyroid cancer	0.000145	0.000555	CcSEcCtD
Morphine—Abdominal pain—Doxorubicin—thyroid cancer	0.000145	0.000555	CcSEcCtD
Morphine—Asthenia—Epirubicin—thyroid cancer	0.000142	0.000545	CcSEcCtD
Morphine—Pruritus—Epirubicin—thyroid cancer	0.00014	0.000537	CcSEcCtD
Morphine—Diarrhoea—Epirubicin—thyroid cancer	0.000136	0.000519	CcSEcCtD
Morphine—Hypersensitivity—Doxorubicin—thyroid cancer	0.000135	0.000518	CcSEcCtD
Morphine—Asthenia—Doxorubicin—thyroid cancer	0.000132	0.000504	CcSEcCtD
Morphine—Dizziness—Epirubicin—thyroid cancer	0.000131	0.000502	CcSEcCtD
Morphine—Pruritus—Doxorubicin—thyroid cancer	0.00013	0.000497	CcSEcCtD
Morphine—Vomiting—Epirubicin—thyroid cancer	0.000126	0.000483	CcSEcCtD
Morphine—Diarrhoea—Doxorubicin—thyroid cancer	0.000126	0.000481	CcSEcCtD
Morphine—Rash—Epirubicin—thyroid cancer	0.000125	0.000479	CcSEcCtD
Morphine—Dermatitis—Epirubicin—thyroid cancer	0.000125	0.000478	CcSEcCtD
Morphine—Headache—Epirubicin—thyroid cancer	0.000124	0.000476	CcSEcCtD
Morphine—CYP3A4—Cytochrome P450 - arranged by substrate type—RXRA—thyroid cancer	0.000124	0.00216	CbGpPWpGaD
Morphine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—thyroid cancer	0.000123	0.00215	CbGpPWpGaD
Morphine—OPRK1—GPCR ligand binding—CALCA—thyroid cancer	0.000123	0.00214	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—CALCB—thyroid cancer	0.000122	0.00213	CbGpPWpGaD
Morphine—Dizziness—Doxorubicin—thyroid cancer	0.000121	0.000465	CcSEcCtD
Morphine—UGT1A8—Metabolism—SLC5A5—thyroid cancer	0.000119	0.00207	CbGpPWpGaD
Morphine—UGT1A1—Metabolism—NDUFA13—thyroid cancer	0.000118	0.00206	CbGpPWpGaD
Morphine—Nausea—Epirubicin—thyroid cancer	0.000118	0.000451	CcSEcCtD
Morphine—OPRM1—GPCR ligand binding—PTCH1—thyroid cancer	0.000118	0.00205	CbGpPWpGaD
Morphine—Vomiting—Doxorubicin—thyroid cancer	0.000117	0.000447	CcSEcCtD
Morphine—OPRD1—Signaling Pathways—TRIM33—thyroid cancer	0.000116	0.00202	CbGpPWpGaD
Morphine—Rash—Doxorubicin—thyroid cancer	0.000116	0.000443	CcSEcCtD
Morphine—Dermatitis—Doxorubicin—thyroid cancer	0.000116	0.000442	CcSEcCtD
Morphine—Headache—Doxorubicin—thyroid cancer	0.000115	0.00044	CcSEcCtD
Morphine—OPRL1—Signaling Pathways—PTCH1—thyroid cancer	0.000113	0.00197	CbGpPWpGaD
Morphine—UGT1A1—Metabolism—CHST14—thyroid cancer	0.000111	0.00193	CbGpPWpGaD
Morphine—UGT2B7—Metabolism—HPGD—thyroid cancer	0.00011	0.00192	CbGpPWpGaD
Morphine—Nausea—Doxorubicin—thyroid cancer	0.000109	0.000417	CcSEcCtD
Morphine—OPRM1—GPCR ligand binding—SST—thyroid cancer	0.000108	0.00188	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—CALCB—thyroid cancer	0.000107	0.00187	CbGpPWpGaD
Morphine—CYP2C8—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	0.000106	0.00184	CbGpPWpGaD
Morphine—OPRD1—GPCR downstream signaling—TSHR—thyroid cancer	0.000106	0.00184	CbGpPWpGaD
Morphine—OPRM1—IL4-mediated signaling events—AKT1—thyroid cancer	0.000104	0.00182	CbGpPWpGaD
Morphine—UGT2B4—Metabolism—SLC5A5—thyroid cancer	0.000104	0.00181	CbGpPWpGaD
Morphine—UGT2B15—Metabolism—SLC5A5—thyroid cancer	0.000104	0.00181	CbGpPWpGaD
Morphine—OPRM1—GPCR ligand binding—CALCA—thyroid cancer	0.000104	0.00181	CbGpPWpGaD
Morphine—OPRL1—Signaling Pathways—SST—thyroid cancer	0.000103	0.0018	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—TRIM33—thyroid cancer	0.000102	0.00177	CbGpPWpGaD
Morphine—CYP3A4—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	0.000101	0.00175	CbGpPWpGaD
Morphine—UGT1A8—Metabolism—RXRA—thyroid cancer	9.99e-05	0.00174	CbGpPWpGaD
Morphine—CYP2C8—Biological oxidations—RXRA—thyroid cancer	9.95e-05	0.00173	CbGpPWpGaD
Morphine—OPRL1—Signaling Pathways—CALCA—thyroid cancer	9.94e-05	0.00173	CbGpPWpGaD
Morphine—OPRD1—Signaling by GPCR—TSHR—thyroid cancer	9.59e-05	0.00167	CbGpPWpGaD
Morphine—OPRD1—Signaling by GPCR—PRKAR1A—thyroid cancer	9.44e-05	0.00165	CbGpPWpGaD
Morphine—OPRK1—GPCR downstream signaling—TSHR—thyroid cancer	9.26e-05	0.00162	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—CALCB—thyroid cancer	9.07e-05	0.00158	CbGpPWpGaD
Morphine—OPRL1—Signaling Pathways—CDK1—thyroid cancer	9e-05	0.00157	CbGpPWpGaD
Morphine—UGT1A1—Metabolism—HPGD—thyroid cancer	8.94e-05	0.00156	CbGpPWpGaD
Morphine—OPRM1—TCR Signaling Pathway—HRAS—thyroid cancer	8.77e-05	0.00153	CbGpPWpGaD
Morphine—UGT2B15—Metabolism—RXRA—thyroid cancer	8.73e-05	0.00152	CbGpPWpGaD
Morphine—UGT2B4—Metabolism—RXRA—thyroid cancer	8.73e-05	0.00152	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—TRIM33—thyroid cancer	8.6e-05	0.0015	CbGpPWpGaD
Morphine—OPRK1—Signaling by GPCR—TSHR—thyroid cancer	8.41e-05	0.00147	CbGpPWpGaD
Morphine—OPRK1—Signaling by GPCR—PRKAR1A—thyroid cancer	8.28e-05	0.00144	CbGpPWpGaD
Morphine—OPRD1—GPCR downstream signaling—SST—thyroid cancer	8.22e-05	0.00143	CbGpPWpGaD
Morphine—CYP2D6—Biological oxidations—RXRA—thyroid cancer	8.17e-05	0.00142	CbGpPWpGaD
Morphine—OPRD1—Signaling by GPCR—PTCH1—thyroid cancer	8.16e-05	0.00142	CbGpPWpGaD
Morphine—ABCB1—Integrated Pancreatic Cancer Pathway—RXRA—thyroid cancer	7.97e-05	0.00139	CbGpPWpGaD
Morphine—OPRD1—GPCR downstream signaling—CALCA—thyroid cancer	7.91e-05	0.00138	CbGpPWpGaD
Morphine—OPRM1—GPCR downstream signaling—TSHR—thyroid cancer	7.83e-05	0.00137	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—TCF7L1—thyroid cancer	7.74e-05	0.00135	CbGpPWpGaD
Morphine—OPRM1—TCR Signaling Pathway—AKT1—thyroid cancer	7.74e-05	0.00135	CbGpPWpGaD
Morphine—OPRD1—Signaling by GPCR—SST—thyroid cancer	7.46e-05	0.0013	CbGpPWpGaD
Morphine—UGT1A3—Metabolism—TPR—thyroid cancer	7.43e-05	0.0013	CbGpPWpGaD
Morphine—UGT1A3—Metabolism—PRKAR1A—thyroid cancer	7.31e-05	0.00128	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—MINPP1—thyroid cancer	7.31e-05	0.00127	CbGpPWpGaD
Morphine—OPRL1—Signaling Pathways—NRG1—thyroid cancer	7.22e-05	0.00126	CbGpPWpGaD
Morphine—OPRK1—GPCR downstream signaling—SST—thyroid cancer	7.2e-05	0.00126	CbGpPWpGaD
Morphine—OPRD1—Signaling by GPCR—CALCA—thyroid cancer	7.18e-05	0.00125	CbGpPWpGaD
Morphine—OPRK1—Signaling by GPCR—PTCH1—thyroid cancer	7.15e-05	0.00125	CbGpPWpGaD
Morphine—OPRM1—Signaling by GPCR—TSHR—thyroid cancer	7.11e-05	0.00124	CbGpPWpGaD
Morphine—OPRM1—Signaling by GPCR—PRKAR1A—thyroid cancer	6.99e-05	0.00122	CbGpPWpGaD
Morphine—OPRK1—GPCR downstream signaling—CALCA—thyroid cancer	6.94e-05	0.00121	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—TCF7L1—thyroid cancer	6.79e-05	0.00118	CbGpPWpGaD
Morphine—OPRK1—Signaling by GPCR—SST—thyroid cancer	6.54e-05	0.00114	CbGpPWpGaD
Morphine—OPRD1—Signaling by GPCR—CDK1—thyroid cancer	6.5e-05	0.00113	CbGpPWpGaD
Morphine—OPRL1—Signaling Pathways—TERT—thyroid cancer	6.48e-05	0.00113	CbGpPWpGaD
Morphine—ABCB1—Metabolism—MINPP1—thyroid cancer	6.37e-05	0.00111	CbGpPWpGaD
Morphine—UGT2B7—Metabolism—TPR—thyroid cancer	6.32e-05	0.0011	CbGpPWpGaD
Morphine—UGT1A8—Metabolism—PPARG—thyroid cancer	6.31e-05	0.0011	CbGpPWpGaD
Morphine—OPRK1—Signaling by GPCR—CALCA—thyroid cancer	6.3e-05	0.0011	CbGpPWpGaD
Morphine—UGT2B7—Metabolism—PRKAR1A—thyroid cancer	6.22e-05	0.00108	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—NDUFA13—thyroid cancer	6.21e-05	0.00108	CbGpPWpGaD
Morphine—OPRL1—Signaling Pathways—HIF1A—thyroid cancer	6.2e-05	0.00108	CbGpPWpGaD
Morphine—OPRM1—GPCR downstream signaling—SST—thyroid cancer	6.09e-05	0.00106	CbGpPWpGaD
Morphine—OPRM1—Signaling by GPCR—PTCH1—thyroid cancer	6.05e-05	0.00105	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—MINPP1—thyroid cancer	6e-05	0.00105	CbGpPWpGaD
Morphine—OPRM1—GPCR downstream signaling—CALCA—thyroid cancer	5.86e-05	0.00102	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—CHST14—thyroid cancer	5.84e-05	0.00102	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—TCF7L1—thyroid cancer	5.74e-05	0.001	CbGpPWpGaD
Morphine—OPRK1—Signaling by GPCR—CDK1—thyroid cancer	5.7e-05	0.000994	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—TSHR—thyroid cancer	5.67e-05	0.000988	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—PRKAR1A—thyroid cancer	5.58e-05	0.000972	CbGpPWpGaD
Morphine—UGT1A3—Metabolism—SLC5A5—thyroid cancer	5.57e-05	0.00097	CbGpPWpGaD
Morphine—OPRM1—Signaling by GPCR—SST—thyroid cancer	5.53e-05	0.000964	CbGpPWpGaD
Morphine—UGT2B15—Metabolism—PPARG—thyroid cancer	5.51e-05	0.000961	CbGpPWpGaD
Morphine—UGT2B4—Metabolism—PPARG—thyroid cancer	5.51e-05	0.000961	CbGpPWpGaD
Morphine—OPRL1—Signaling by GPCR—NRAS—thyroid cancer	5.46e-05	0.000953	CbGpPWpGaD
Morphine—ABCB1—Metabolism—NDUFA13—thyroid cancer	5.41e-05	0.000944	CbGpPWpGaD
Morphine—CYP3A4—Biological oxidations—RXRA—thyroid cancer	5.34e-05	0.000931	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—MEN1—thyroid cancer	5.33e-05	0.000929	CbGpPWpGaD
Morphine—OPRM1—Signaling by GPCR—CALCA—thyroid cancer	5.32e-05	0.000928	CbGpPWpGaD
Morphine—UGT1A1—Metabolism—TPR—thyroid cancer	5.14e-05	0.000896	CbGpPWpGaD
Morphine—OPRL1—Signaling Pathways—BRAF—thyroid cancer	5.14e-05	0.000895	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—NDUFA13—thyroid cancer	5.1e-05	0.000889	CbGpPWpGaD
Morphine—ABCB1—Metabolism—CHST14—thyroid cancer	5.09e-05	0.000887	CbGpPWpGaD
Morphine—UGT1A1—Metabolism—PRKAR1A—thyroid cancer	5.05e-05	0.000881	CbGpPWpGaD
Morphine—ABCB1—Transmembrane transport of small molecules—CP—thyroid cancer	5.03e-05	0.000877	CbGpPWpGaD
Morphine—ABCB1—Transmembrane transport of small molecules—TPR—thyroid cancer	5.03e-05	0.000877	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—TSHR—thyroid cancer	4.97e-05	0.000867	CbGpPWpGaD
Morphine—UGT1A8—Metabolism—PTGS2—thyroid cancer	4.96e-05	0.000865	CbGpPWpGaD
Morphine—ABCB1—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	4.95e-05	0.000863	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—PRKAR1A—thyroid cancer	4.89e-05	0.000852	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—PTCH1—thyroid cancer	4.82e-05	0.00084	CbGpPWpGaD
Morphine—OPRM1—Signaling by GPCR—CDK1—thyroid cancer	4.82e-05	0.00084	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—CHST14—thyroid cancer	4.8e-05	0.000836	CbGpPWpGaD
Morphine—UGT2B7—Metabolism—SLC5A5—thyroid cancer	4.73e-05	0.000825	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—HPGD—thyroid cancer	4.71e-05	0.000821	CbGpPWpGaD
Morphine—OPRL1—Signaling by GPCR—KRAS—thyroid cancer	4.7e-05	0.00082	CbGpPWpGaD
Morphine—UGT1A3—Metabolism—RXRA—thyroid cancer	4.68e-05	0.000815	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—MEN1—thyroid cancer	4.67e-05	0.000815	CbGpPWpGaD
Morphine—ABCB1—HIF-1-alpha transcription factor network—AKT1—thyroid cancer	4.66e-05	0.000812	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—SST—thyroid cancer	4.41e-05	0.000768	CbGpPWpGaD
Morphine—UGT2B4—Metabolism—PTGS2—thyroid cancer	4.34e-05	0.000756	CbGpPWpGaD
Morphine—UGT2B15—Metabolism—PTGS2—thyroid cancer	4.34e-05	0.000756	CbGpPWpGaD
Morphine—UGT1A8—Metabolism—PTEN—thyroid cancer	4.33e-05	0.000754	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—CALCA—thyroid cancer	4.24e-05	0.00074	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—PTCH1—thyroid cancer	4.23e-05	0.000737	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—TSHR—thyroid cancer	4.2e-05	0.000732	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—PRKAR1A—thyroid cancer	4.13e-05	0.00072	CbGpPWpGaD
Morphine—ABCB1—Metabolism—HPGD—thyroid cancer	4.1e-05	0.000715	CbGpPWpGaD
Morphine—OPRL1—Signaling by GPCR—HRAS—thyroid cancer	4e-05	0.000697	CbGpPWpGaD
Morphine—UGT2B7—Metabolism—RXRA—thyroid cancer	3.98e-05	0.000693	CbGpPWpGaD
Morphine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—thyroid cancer	3.96e-05	0.00069	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—MEN1—thyroid cancer	3.95e-05	0.000689	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—MINPP1—thyroid cancer	3.92e-05	0.000684	CbGpPWpGaD
Morphine—OPRL1—GPCR downstream signaling—AKT1—thyroid cancer	3.89e-05	0.000678	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—HPGD—thyroid cancer	3.87e-05	0.000674	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—SST—thyroid cancer	3.86e-05	0.000674	CbGpPWpGaD
Morphine—UGT1A1—Metabolism—SLC5A5—thyroid cancer	3.85e-05	0.00067	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—CDK1—thyroid cancer	3.84e-05	0.00067	CbGpPWpGaD
Morphine—CYP2C8—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	3.82e-05	0.000666	CbGpPWpGaD
Morphine—UGT2B15—Metabolism—PTEN—thyroid cancer	3.78e-05	0.000659	CbGpPWpGaD
Morphine—UGT2B4—Metabolism—PTEN—thyroid cancer	3.78e-05	0.000659	CbGpPWpGaD
Morphine—ABCB1—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	3.77e-05	0.000657	CbGpPWpGaD
Morphine—OPRL1—Signaling Pathways—CCND1—thyroid cancer	3.75e-05	0.000653	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—CALCA—thyroid cancer	3.72e-05	0.000649	CbGpPWpGaD
Morphine—OPRL1—Signaling Pathways—PTEN—thyroid cancer	3.62e-05	0.000631	CbGpPWpGaD
Morphine—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—thyroid cancer	3.58e-05	0.000624	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—PTCH1—thyroid cancer	3.57e-05	0.000623	CbGpPWpGaD
Morphine—OPRL1—Signaling by GPCR—AKT1—thyroid cancer	3.53e-05	0.000615	CbGpPWpGaD
Morphine—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—thyroid cancer	3.45e-05	0.000602	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—CDK1—thyroid cancer	3.37e-05	0.000587	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—NDUFA13—thyroid cancer	3.34e-05	0.000582	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—SST—thyroid cancer	3.27e-05	0.00057	CbGpPWpGaD
Morphine—UGT1A1—Metabolism—RXRA—thyroid cancer	3.23e-05	0.000563	CbGpPWpGaD
Morphine—OPRL1—Signaling Pathways—NRAS—thyroid cancer	3.23e-05	0.000563	CbGpPWpGaD
Morphine—ABCB1—Transmembrane transport of small molecules—RXRA—thyroid cancer	3.16e-05	0.000552	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—CALCA—thyroid cancer	3.14e-05	0.000548	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—CHST14—thyroid cancer	3.14e-05	0.000547	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—NRG1—thyroid cancer	3.08e-05	0.000537	CbGpPWpGaD
Morphine—UGT1A3—Metabolism—PPARG—thyroid cancer	2.95e-05	0.000515	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—CDK1—thyroid cancer	2.85e-05	0.000496	CbGpPWpGaD
Morphine—OPRL1—Signaling Pathways—KRAS—thyroid cancer	2.78e-05	0.000484	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—TERT—thyroid cancer	2.77e-05	0.000483	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—TPR—thyroid cancer	2.7e-05	0.000472	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—NRG1—thyroid cancer	2.7e-05	0.000471	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—PRKAR1A—thyroid cancer	2.66e-05	0.000464	CbGpPWpGaD
Morphine—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—thyroid cancer	2.65e-05	0.000462	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—HIF1A—thyroid cancer	2.65e-05	0.000462	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—HPGD—thyroid cancer	2.53e-05	0.000441	CbGpPWpGaD
Morphine—UGT2B7—Metabolism—PPARG—thyroid cancer	2.51e-05	0.000438	CbGpPWpGaD
Morphine—UGT1A8—Metabolism—AKT1—thyroid cancer	2.49e-05	0.000435	CbGpPWpGaD
Morphine—OPRL1—Signaling Pathways—TP53—thyroid cancer	2.47e-05	0.00043	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—TERT—thyroid cancer	2.43e-05	0.000423	CbGpPWpGaD
Morphine—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	2.41e-05	0.000421	CbGpPWpGaD
Morphine—OPRL1—Signaling Pathways—HRAS—thyroid cancer	2.36e-05	0.000412	CbGpPWpGaD
Morphine—ABCB1—Metabolism—TPR—thyroid cancer	2.36e-05	0.000411	CbGpPWpGaD
Morphine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—thyroid cancer	2.36e-05	0.000411	CbGpPWpGaD
Morphine—OPRD1—Signaling by GPCR—NRAS—thyroid cancer	2.33e-05	0.000407	CbGpPWpGaD
Morphine—UGT1A3—Metabolism—PTGS2—thyroid cancer	2.32e-05	0.000405	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—HIF1A—thyroid cancer	2.32e-05	0.000405	CbGpPWpGaD
Morphine—ABCB1—Metabolism—PRKAR1A—thyroid cancer	2.32e-05	0.000404	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—NRG1—thyroid cancer	2.28e-05	0.000398	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—TPR—thyroid cancer	2.22e-05	0.000387	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—BRAF—thyroid cancer	2.19e-05	0.000382	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—PRKAR1A—thyroid cancer	2.18e-05	0.000381	CbGpPWpGaD
Morphine—UGT2B4—Metabolism—AKT1—thyroid cancer	2.18e-05	0.00038	CbGpPWpGaD
Morphine—UGT2B15—Metabolism—AKT1—thyroid cancer	2.18e-05	0.00038	CbGpPWpGaD
Morphine—OPRL1—Signaling Pathways—AKT1—thyroid cancer	2.08e-05	0.000363	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—TERT—thyroid cancer	2.05e-05	0.000358	CbGpPWpGaD
Morphine—OPRK1—Signaling by GPCR—NRAS—thyroid cancer	2.04e-05	0.000357	CbGpPWpGaD
Morphine—UGT1A1—Metabolism—PPARG—thyroid cancer	2.04e-05	0.000356	CbGpPWpGaD
Morphine—UGT1A3—Metabolism—PTEN—thyroid cancer	2.03e-05	0.000353	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—SLC5A5—thyroid cancer	2.02e-05	0.000353	CbGpPWpGaD
Morphine—OPRD1—Signaling by GPCR—KRAS—thyroid cancer	2.01e-05	0.00035	CbGpPWpGaD
Morphine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—thyroid cancer	1.99e-05	0.000347	CbGpPWpGaD
Morphine—UGT2B7—Metabolism—PTGS2—thyroid cancer	1.97e-05	0.000344	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—HIF1A—thyroid cancer	1.96e-05	0.000342	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—BRAF—thyroid cancer	1.92e-05	0.000335	CbGpPWpGaD
Morphine—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	1.9e-05	0.000331	CbGpPWpGaD
Morphine—ABCB1—Metabolism—SLC5A5—thyroid cancer	1.76e-05	0.000308	CbGpPWpGaD
Morphine—OPRK1—Signaling by GPCR—KRAS—thyroid cancer	1.76e-05	0.000307	CbGpPWpGaD
Morphine—OPRM1—Signaling by GPCR—NRAS—thyroid cancer	1.73e-05	0.000301	CbGpPWpGaD
Morphine—UGT2B7—Metabolism—PTEN—thyroid cancer	1.72e-05	0.0003	CbGpPWpGaD
Morphine—OPRD1—Signaling by GPCR—HRAS—thyroid cancer	1.71e-05	0.000297	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—RXRA—thyroid cancer	1.7e-05	0.000297	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—SLC5A5—thyroid cancer	1.66e-05	0.00029	CbGpPWpGaD
Morphine—OPRD1—GPCR downstream signaling—AKT1—thyroid cancer	1.66e-05	0.000289	CbGpPWpGaD
Morphine—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	1.65e-05	0.000289	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—BRAF—thyroid cancer	1.62e-05	0.000283	CbGpPWpGaD
Morphine—UGT1A1—Metabolism—PTGS2—thyroid cancer	1.6e-05	0.00028	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—CCND1—thyroid cancer	1.6e-05	0.000279	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—PTEN—thyroid cancer	1.54e-05	0.000269	CbGpPWpGaD
Morphine—OPRD1—Signaling by GPCR—AKT1—thyroid cancer	1.51e-05	0.000263	CbGpPWpGaD
Morphine—OPRK1—Signaling by GPCR—HRAS—thyroid cancer	1.5e-05	0.000261	CbGpPWpGaD
Morphine—OPRM1—Signaling by GPCR—KRAS—thyroid cancer	1.49e-05	0.000259	CbGpPWpGaD
Morphine—ABCB1—Metabolism—RXRA—thyroid cancer	1.48e-05	0.000258	CbGpPWpGaD
Morphine—OPRK1—GPCR downstream signaling—AKT1—thyroid cancer	1.45e-05	0.000254	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—TPR—thyroid cancer	1.45e-05	0.000253	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—PRKAR1A—thyroid cancer	1.43e-05	0.000249	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—CCND1—thyroid cancer	1.4e-05	0.000245	CbGpPWpGaD
Morphine—UGT1A1—Metabolism—PTEN—thyroid cancer	1.4e-05	0.000244	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—RXRA—thyroid cancer	1.4e-05	0.000244	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—NRAS—thyroid cancer	1.38e-05	0.00024	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—PTEN—thyroid cancer	1.35e-05	0.000236	CbGpPWpGaD
Morphine—OPRK1—Signaling by GPCR—AKT1—thyroid cancer	1.32e-05	0.00023	CbGpPWpGaD
Morphine—OPRM1—Signaling by GPCR—HRAS—thyroid cancer	1.26e-05	0.00022	CbGpPWpGaD
Morphine—OPRM1—GPCR downstream signaling—AKT1—thyroid cancer	1.23e-05	0.000214	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—NRAS—thyroid cancer	1.21e-05	0.000211	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—KRAS—thyroid cancer	1.19e-05	0.000207	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—CCND1—thyroid cancer	1.19e-05	0.000207	CbGpPWpGaD
Morphine—UGT1A3—Metabolism—AKT1—thyroid cancer	1.17e-05	0.000204	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—PTEN—thyroid cancer	1.14e-05	0.0002	CbGpPWpGaD
Morphine—OPRM1—Signaling by GPCR—AKT1—thyroid cancer	1.12e-05	0.000195	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—SLC5A5—thyroid cancer	1.09e-05	0.000189	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—PPARG—thyroid cancer	1.07e-05	0.000187	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—TP53—thyroid cancer	1.05e-05	0.000184	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—KRAS—thyroid cancer	1.04e-05	0.000181	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—NRAS—thyroid cancer	1.02e-05	0.000178	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—HRAS—thyroid cancer	1.01e-05	0.000176	CbGpPWpGaD
Morphine—UGT2B7—Metabolism—AKT1—thyroid cancer	9.93e-06	0.000173	CbGpPWpGaD
Morphine—ABCB1—Metabolism—PPARG—thyroid cancer	9.36e-06	0.000163	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—TP53—thyroid cancer	9.24e-06	0.000161	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—RXRA—thyroid cancer	9.13e-06	0.000159	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—AKT1—thyroid cancer	8.9e-06	0.000155	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—HRAS—thyroid cancer	8.84e-06	0.000154	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—PPARG—thyroid cancer	8.82e-06	0.000154	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—KRAS—thyroid cancer	8.79e-06	0.000153	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—PTGS2—thyroid cancer	8.45e-06	0.000147	CbGpPWpGaD
Morphine—UGT1A1—Metabolism—AKT1—thyroid cancer	8.07e-06	0.000141	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—TP53—thyroid cancer	7.81e-06	0.000136	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—AKT1—thyroid cancer	7.8e-06	0.000136	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—HRAS—thyroid cancer	7.47e-06	0.00013	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—PTEN—thyroid cancer	7.37e-06	0.000128	CbGpPWpGaD
Morphine—ABCB1—Metabolism—PTGS2—thyroid cancer	7.36e-06	0.000128	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—PTGS2—thyroid cancer	6.94e-06	0.000121	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—AKT1—thyroid cancer	6.59e-06	0.000115	CbGpPWpGaD
Morphine—ABCB1—Metabolism—PTEN—thyroid cancer	6.42e-06	0.000112	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—PTEN—thyroid cancer	6.05e-06	0.000105	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—PPARG—thyroid cancer	5.77e-06	0.000101	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—PTGS2—thyroid cancer	4.54e-06	7.91e-05	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—AKT1—thyroid cancer	4.25e-06	7.4e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—PTEN—thyroid cancer	3.96e-06	6.9e-05	CbGpPWpGaD
Morphine—ABCB1—Metabolism—AKT1—thyroid cancer	3.7e-06	6.45e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—AKT1—thyroid cancer	3.49e-06	6.08e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—AKT1—thyroid cancer	2.28e-06	3.97e-05	CbGpPWpGaD
